Kim & Chang advised ARCHIMED in its acquisition of 100% equity interests in Jeisys Medical.

In this deal, our firm provided comprehensive legal services in connection with the following transactions: (i) the acquisition of controlling equity interests from the majority shareholder, which involved negotiating transaction terms, conducting legal due diligence on the target and its overseas subsidiaries, finalizing and executing contracts, and closing the deal, (ii) the acquisition of the remaining equity interests from minority shareholders by way of two tender offers and a comprehensive stock swap, and (iii) other complex procedures to transform the target company into a 100% wholly-owned subsidiary.

This matter marks ARCHIMED’s first investment in Korea and also sets a precedent as the first instance of a foreign private equity fund transforming a Korean listed company into a wholly-owned private subsidiary. We provided comprehensive legal advice to facilitate an exceedingly complex transaction structure, which required consideration of capital market laws and other relevant legislations, public disclosures regime, tax issues and foreign exchange issues, among others.

Our services enabled the client to navigate these processes smoothly, culminating in the successful closing of a groundbreaking domestic case that entailed the transformation of a listed company into a wholly-owned private company.